US Stock MarketDetailed Quotes
LTRN Lantern Pharma
- 3.310
- +0.185+5.92%
Close Nov 1 16:00 ET
- 3.310
- 0.0000.00%
Post 20:02 ET
35.63MMarket Cap-2006P/E (TTM)
3.310High3.050Low20.49KVolume3.080Open3.125Pre Close66.08KTurnover0.26%Turnover RatioLossP/E (Static)10.76MShares11.99052wk High1.15P/B26.29MFloat Cap2.74052wk Low--Dividend TTM7.94MShs Float24.840Historical High--Div YieldTTM8.32%Amplitude2.380Historical Low3.224Avg Price1Lot Size
About Lantern Pharma Company
Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.
Company Profile
SymbolLTRN
Company NameLantern Pharma
Listing DateJun 11, 2020
Issue Price15.00
Founded2013
CEOMr. Panna L. Sharma
MarketNASDAQ
Employees21
Fiscal Year Ends12-31
Address1920 McKinney Avenue,7th floor
CityDallas
ProvinceTexas
CountryUnited States of America
Zip Code75201
Phone1-972-277-1136
Websitehttp://www.lanternpharma.com
Company Executives
- Name
- Position
- Salary
- Panna L. Sharma
- Chief Executive Officer, President and Director
- 684.39K
- David R. Margrave
- Principal Accounting Officer, Chief Financial Officer and Secretary
- 442.68K
- Dr. Kishor G. Bhatia, PhD
- Chief Scientific Officer
- 283.24K
- Donald Jeffrey Keyser
- Chairman of the Board
- 56.00K
- David S. Silberstein
- Director
- 46.00K
- Dr. Vijay Chandru
- Independent Director
- 46.00K
- Dr. Maria Maccecchini, PhD
- Independent Director
- 51.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data